טוען...
Anti‐vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema
BACKGROUND: The combination of steroid and anti‐vascular endothelial growth factor (VEGF) intravitreal therapeutic agents could potentially have synergistic effects for treating diabetic macular oedema (DMO). On the one hand, if combined treatment is more effective than monotherapy, there would be s...
שמור ב:
| הוצא לאור ב: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley & Sons, Ltd
2018
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6494419/ https://ncbi.nlm.nih.gov/pubmed/29669176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011599.pub2 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|